Lymph node ratio as a tool to stratify patients with N1b papillary thyroid cancer

被引:0
|
作者
Luo, Ziyu [1 ,2 ]
Hei, Hu [1 ,2 ]
Qin, Jianwu [1 ,2 ]
Zheng, Chen [1 ,2 ]
Gong, Wenbo [1 ,2 ]
Zhou, Bin [1 ,2 ]
机构
[1] Zhengzhou Univ, Affiliated Canc Hosp, Dept Thyroid & Neck, Zhengzhou 450008, Peoples R China
[2] Henan Canc Hosp, Zhengzhou 450008, Peoples R China
关键词
Papillary thyroid cancer; Lymph node ratio; Disease-specific mortality; Overall survival; SEER; SURVIVAL; IMPACT;
D O I
10.1007/s00423-023-03033-w
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundThe prognostic significance of lymph node ratio (LNR) in N1b papillary thyroid cancer is unclear. Therefore, the impact of LNR on disease-specific mortality (DSM) and overall survival (OS) in patients with N1b papillary thyroid cancer (PTC) needs to be defined.MethodsWe used the Surveillance, Epidemiology, and End Results (SEER) database of patients who had undergone thyroidectomy and lymph node dissection. Factors associated with DSM and OS were analyzed and identified using univariate and multivariate Cox proportional risk models. X-tile software was used to find the best cutoff value of LNR. Kaplan-Meier estimates for DSM were plotted for LNR and were compared with the log-rank test. The ROC curve evaluated the validity of the model.ResultsA total of 3223 patients with N1b PTC were identified in the SEER database between 1975 and 2019. The best cutoff value for LNR was 0.6. The multivariate Cox proportional risk model showed that age, race, T3/T4 classification, distant metastasis, extent of surgery, number of metastatic lymph nodes, and LNR > 0.6 were independent risk factors for DSM (all p < 0.05). Age, sex, T4 classification, distant metastasis, extent of surgery, and LNR > 0.6 were independent risk factors for OS (all p < 0.05). The Kaplan-Meier method plotted a cumulative risk curve and showed that patients with LNR > 0.6 had a significantly higher risk of DSM than patients with LNR & LE; 0.6 (p = 0.002).ConclusionLNR was a powerful predictor of DSM and OS in N1b PTC patients. LNR could be a useful tool for the stratification of PTC patients with lateral neck metastases.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Prognostic Implications of Lymph Node Yield and Lymph Node Ratio in Papillary Thyroid Carcinoma
    Nunes, Jonathan H. Vas
    Clark, Jonathan R.
    Gao, Kan
    Chua, Elizabeth
    Campbell, Peter
    Niles, Navin
    Gargya, Ash
    Elliott, Michael S.
    THYROID, 2013, 23 (07) : 811 - 816
  • [42] Factors Related to Lymph Node Recurrence in Patients with N1b Papillary Thyroid Carcinoma after Unilateral Therapeutic Modified Radical Neck Dissection: A Meta-analysis
    Su, Hui
    Li, Yujie
    ZENTRALBLATT FUR CHIRURGIE, 2018, 143 (04): : 373 - 379
  • [43] Should Level V Be Routinely Dissected in N1b Papillary Thyroid Carcinoma?
    Kim, Seo Ki
    Park, Inhye
    Hur, Nayoon
    Lee, Jun Ho
    Choe, Jun-Ho
    Kim, Jung-Han
    Kim, Jee Soo
    THYROID, 2017, 27 (02) : 253 - 260
  • [44] Clinical Outcomes of N1b Papillary Thyroid Cancer Patients Treated with Two Different Doses of Radioiodine Ablation Therapy
    Jin, Meihua
    Ahn, Jonghwa
    Lee, Yu-Mi
    Sung, Tae-Yon
    Kim, Won Gu
    Kim, Tae Yong
    Ryu, Jin-Sook
    Kim, Won
    Shong, Young Kee
    Jeon, Min Ji
    ENDOCRINOLOGY AND METABOLISM, 2020, 35 (03) : 602 - 609
  • [45] Differentiated Thyroid Cancer: The Role ofATANodal Risk Factors in N1b Patients
    Taboni, Stefano
    Paderno, Alberto
    Giordano, Davide
    Albano, Domenico
    Piana, Simonetta
    Zanetti, Eleonora
    Bertagna, Francesco
    Grammatica, Alberto
    Ghidini, Angelo
    Cappelli, Carlo
    Bozzola, Anna
    Baronchelli, Carla
    Nicolai, Piero
    Lombardi, Davide
    LARYNGOSCOPE, 2021, 131 (03): : E1029 - E1034
  • [46] Association of Lymph Node Density With Survival of Patients With Papillary Thyroid Cancer
    Amit, Moran
    Tam, Samantha
    Boonsripitayanon, Mongkol
    Cabanillas, Maria E.
    Busaidy, Naifa L.
    Grubbs, Elizabeth Gardner
    Lai, Stephen Y.
    Gross, Neil D.
    Sturgis, Erich M.
    Zafereo, Mark E.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2018, 144 (02) : 108 - 114
  • [47] UNFAVORABLE RESPONSES TO RADIOIODINE THERAPY IN N1B PAPILLARY THYROID CANCER: A PROPENSITY SCORE MATCHING STUDY
    Liu, Yan-Qing
    Li, Hui
    Liu, Jie-Rui
    Lin, Yan-Song
    ENDOCRINE PRACTICE, 2019, 25 (12) : 1286 - 1294
  • [48] Histopathological Characteristics of N1b Papillary Thyroid Carcinoma are Associated with Risk of Recurrence
    Carmel Neiderman, Narin N.
    Duek, Irit
    Kuzmenko, Boris
    Ringel, Barak
    Warshavsky, Anton
    Muhanna, Nidal
    Horowitz, Gilad
    Fliss, Dan M.
    WORLD JOURNAL OF SURGERY, 2022, 46 (08) : 1917 - 1925
  • [49] Risk Factors for Recurrence After Treatment of N1b Papillary Thyroid Carcinoma
    Lee, Sang Hun
    Roh, Jong-Lyel
    Gong, Gyungyup
    Cho, Kyung-Ja
    Choi, Seung-Ho
    Nam, Soon Yuhl
    Kim, Sang Yoon
    ANNALS OF SURGERY, 2019, 269 (05) : 966 - 971
  • [50] Lymph node ratio independently associated with postoperative thyroglobulin levels in papillary thyroid cancer
    Hei, Hu
    Luo, Ziyu
    Zheng, Chen
    Gong, Wenbo
    Zhou, Bin
    Fang, Jugao
    Qin, Jianwu
    ORAL ONCOLOGY, 2023, 146